These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 29277141)

  • 1. In silico studies of conformational dynamics of Mu opioid receptor performed using gaussian accelerated molecular dynamics.
    Liao JM; Wang YT
    J Biomol Struct Dyn; 2019 Jan; 37(1):166-177. PubMed ID: 29277141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the molecular basis of agonist/antagonist mechanism of human mu opioid receptor through gaussian accelerated molecular dynamics method.
    Wang YT; Chan YH
    Sci Rep; 2017 Aug; 7(1):7828. PubMed ID: 28798303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Oliceridine (TRV-130) Binds and Stabilizes a μ-Opioid Receptor Conformational State That Selectively Triggers G Protein Signaling Pathways.
    Schneider S; Provasi D; Filizola M
    Biochemistry; 2016 Nov; 55(46):6456-6466. PubMed ID: 27778501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand based conformational space studies of the μ-opioid receptor.
    Sena DM; Cong X; Giorgetti A
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129838. PubMed ID: 33373630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Does Agonist and Antagonist Binding Lead to Different Conformational Ensemble Equilibria of the κ-Opioid Receptor: Insight from Long-Time Gaussian Accelerated Molecular Dynamics Simulation.
    An X; Bai Q; Bing Z; Zhou S; Shi D; Liu H; Yao X
    ACS Chem Neurosci; 2019 Mar; 10(3):1575-1584. PubMed ID: 30372027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational insights into the molecular mechanisms of differentiated allosteric modulation at the mu opioid receptor by structurally similar bitopic modulators.
    Wang H; Reinecke BA; Zhang Y
    J Comput Aided Mol Des; 2020 Aug; 34(8):879-895. PubMed ID: 32193867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atomic-Level Characterization of the Methadone-Stabilized Active Conformation of
    Kapoor A; Provasi D; Filizola M
    Mol Pharmacol; 2020 Oct; 98(4):475-486. PubMed ID: 32680919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric modulation model of the mu opioid receptor by herkinorin, a potent not alkaloidal agonist.
    Marmolejo-Valencia AF; Martínez-Mayorga K
    J Comput Aided Mol Des; 2017 May; 31(5):467-482. PubMed ID: 28364251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of allosteric probe dependence in μ opioid receptor.
    Bartuzi D; Kaczor AA; Matosiuk D
    J Biomol Struct Dyn; 2019 Jan; 37(1):36-47. PubMed ID: 29241414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular docking reveals a novel binding site model for fentanyl at the mu-opioid receptor.
    Subramanian G; Paterlini MG; Portoghese PS; Ferguson DM
    J Med Chem; 2000 Feb; 43(3):381-91. PubMed ID: 10669565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and functional interactions between six-transmembrane μ-opioid receptors and β2-adrenoreceptors modulate opioid signaling.
    Samoshkin A; Convertino M; Viet CT; Wieskopf JS; Kambur O; Marcovitz J; Patel P; Stone LS; Kalso E; Mogil JS; Schmidt BL; Maixner W; Dokholyan NV; Diatchenko L
    Sci Rep; 2015 Dec; 5():18198. PubMed ID: 26657998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An efficient strategy to estimate thermodynamics and kinetics of G protein-coupled receptor activation using metadynamics and maximum caliber.
    Meral D; Provasi D; Filizola M
    J Chem Phys; 2018 Dec; 149(22):224101. PubMed ID: 30553249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic and thermodynamic insights into sodium ion translocation through the μ-opioid receptor from molecular dynamics and machine learning analysis.
    Hu X; Wang Y; Hunkele A; Provasi D; Pasternak GW; Filizola M
    PLoS Comput Biol; 2019 Jan; 15(1):e1006689. PubMed ID: 30677023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-substituted tetrahydro-beta-carboline as mu-opioid receptors ligands: in silico study; molecular docking, ADMET and molecular dynamics approach.
    Alananzeh WA; Al-Qattan MN; Ayipo YO; Mordi MN
    Mol Divers; 2024 Jun; 28(3):1273-1289. PubMed ID: 37133710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational Heterogeneity of Intracellular Loop 3 of the μ-opioid G-protein Coupled Receptor.
    Huang J; Lakkaraju SK; Coop A; MacKerell AD
    J Phys Chem B; 2016 Nov; 120(46):11897-11904. PubMed ID: 27801588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic and Kinetic Elements of µ-Opioid Receptor Functional Selectivity.
    Kapoor A; Martinez-Rosell G; Provasi D; de Fabritiis G; Filizola M
    Sci Rep; 2017 Sep; 7(1):11255. PubMed ID: 28900175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics of fentanyl bound to μ-opioid receptor.
    Lipiński PFJ; Jarończyk M; Dobrowolski JC; Sadlej J
    J Mol Model; 2019 May; 25(5):144. PubMed ID: 31053968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propagation of conformational changes during μ-opioid receptor activation.
    Sounier R; Mas C; Steyaert J; Laeremans T; Manglik A; Huang W; Kobilka BK; Déméné H; Granier S
    Nature; 2015 Aug; 524(7565):375-8. PubMed ID: 26245377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Lipid Composition and Receptor Conformation on the Spatio-temporal Organization of μ-Opioid Receptors in a Multi-component Plasma Membrane Model.
    Marino KA; Prada-Gracia D; Provasi D; Filizola M
    PLoS Comput Biol; 2016 Dec; 12(12):e1005240. PubMed ID: 27959924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational insights into the G-protein-biased activation and inactivation mechanisms of the μ opioid receptor.
    Cheng JX; Cheng T; Li WH; Liu GX; Zhu WL; Tang Y
    Acta Pharmacol Sin; 2018 Jan; 39(1):154-164. PubMed ID: 29188799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.